Once-Weekly Semaglutide in Adults with Overweight or Obesity | Zendy

John Wilding | Zendy; Rachel L. Batterham | Zendy; Salvatore Calanna | Zendy; Melanie J. Davies | Zendy; Luc F. Van Gaal | Zendy; Ildiko Lingvay | Zendy; Barbara McGowan | Zendy; Julio Rosenstock | Zendy; Marie Thi Dao Tran | Zendy; Thomas A. Wadden | Zendy; Sean Wharton | Zendy; Koutaro Yokote | Zendy; Niels Zeuthen | Zendy; Robert F. Kushner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Author(s) -

John Wilding,

Rachel L. Batterham,

Salvatore Calanna,

Melanie J. Davies,

Luc F. Van Gaal,

Ildiko Lingvay,

Barbara McGowan,

Julio Rosenstock,

Marie Thi Dao Tran,

Thomas A. Wadden,

Sean Wharton,

Koutaro Yokote,

Niels Zeuthen,

Robert F. Kushner

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2032183

Subject(s) - semaglutide , obesity , overweight , medicine , weight loss , intervention (counseling) , endocrinology , diabetes mellitus , type 2 diabetes , psychiatry , liraglutide

Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle intervention has not been confirmed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research